Fatmaria Fatmaria

Fatmaria Fatmaria

Auto-generated profile, based on publicly available information

Fatmaria Fatmaria

Department of Pharmacotherapy, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya, Indonesia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2024 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
DSDio Syahputra
Dio Syahputra
YYYsrafil Ysrafil
Ysrafil Ysrafil
FAFRANCISCA DIANA Alexandra
FRANCISCA DIANA Alexandra
Rian Ka PrajaRian Ka Praja
Rian Ka Praja
FFFatmaria Fatmaria
Fatmaria Fatmaria
RPRemi Ayu Pratika
Remi Ayu Pratika
Background: Prostate cancer is the most common oncological disease in men and one of leading causes of death worldwide. Growing evidence has demonstrated the effectiveness of mung bean bioactive compounds in suppressing various cancer cells. However, their effects and underlying mechanisms on prostate cancer have not been verified. The present study aimed to investigate the therapeutical effects and underlying mechanisms of mung bean compounds against prostate cancer. Results: The results revealed that 56 proteins related to prostate cancer could be modulated by mung bean, including several vital proteins of SRC (Sarcoma), Mitogen-Activated Protein Kinase 8 (MAPK8), Heat shock protein 90 kDa alpha member A1 (HSP90AA1), and Harvey Rat sarcoma virus (HRAS). It was also found that the potential pathways associated with prostate cancer pathogenesis comprising pyrimidine metabolism, nitrogen metabolism, and prolactin signaling pathways. Of 19 mung bean compounds docked to four key proteins reveal three promising compound (dulcinoside, peonidin-3-glucoside, and chlorogenic acid) with lower binding affinity score of − 7.7, − 12.2, − 9.0, and − 6.5 kcal/mol against SRC, MAPK8, HSP90AA1, and HRAS, respectively in their site of action. Dynamic simulation results also showed values of − 36.52 ± 2.93, − 35.93 ± 1.67, and − 35.77 ± 1.17 kJ/mol for Dulcinoside-SRC, Dulcinoside-MAPK8, and P3G-HSP90AA1 complexes, respectively. The binding of the compound occur in stable and flexible with the proteins. Moreover, all mung bean compounds predicted to have good ADMET properties. Conclusions: The study concluded that dulcinoside, peonidin-3-glucoside, and chlorogenic acid potentially exhibited anticancer activity against prostate cancer in silico. Nevertheless, further studies such as in vitro and in vivo are needed to optimize and prove the efficacy of the mung brand and its compounds against prostate cancer. Graphical

14 January 2026 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Closed access
PDF file
YYYsrafil Ysrafil
Ysrafil Ysrafil
FAFRANCISCA DIANA Alexandra
FRANCISCA DIANA Alexandra
ETElsa Trinovita
Elsa Trinovita
FFFatmaria Fatmaria
Fatmaria Fatmaria
AFAgnes Frethernety
Agnes Frethernety
Firzan NainuFirzan Nainu
Firzan Nainu

8 August 2024 in Majalah Obat Tradisional
Verified
Journal Article
Open access
PDF file
CSChristine Sirait
Christine Sirait
HHHanasia Hanasia
Hanasia Hanasia
NMNatalia Sri Martani
Natalia Sri Martani
YYYsrafil Ysrafil
Ysrafil Ysrafil
FFFatmaria Fatmaria
Fatmaria Fatmaria
Typhoid fever is caused by consuming food or water contaminated with Salmonella typhi. The disease develops from bacterial infection through the consumption of contaminated sustenance and drink. The bacterium can cause bacteremia, which is bacteria living in the blood, penetrating the mucosal epithelium of the small intestine and entering the lymphatic flow. Therefore, this study aimed to assess the potential inhibitory effect of ethanol extracts derived from stems of Eurycoma longifolia (pasak bumi) on the growth of Salmonella typhi bacteria. Compounds such as alkaloids, saponins, flavonoids, terpenoids, and tannins in pasak bumi stems possessed antibacterial properties. Extracts were made using 96% ethanol at varying concentrations (10%, 20%, 30%, 40%, 50%) with distilled water and chloramphenicol as negative and positive control. The result showed that pasak bumi stem extracts inhibited Salmonella typhi, with increasing efficacy at higher concentrations and statistical analysis reported significant differences between all treatment groups (p<0.001). Average zone diameter was 0 mm and 23.10 mm for negative and positive control, as well as 2.75 mm, 4.10 mm, 5.24 mm, 6.98 mm, and 8.55 mm for 10%, 20%, 30%, 40% and 50% extracts, respectively. This study provided verification of antibacterial effects of pasak bumi stem ethanol extracts against Salmonella typhi.

29 June 2025 in Bioactivities
Verified
Journal Article
Open access
PDF file
DADewanti Agustira
Dewanti Agustira
YYYsrafil Ysrafil
Ysrafil Ysrafil
FFFatmaria Fatmaria
Fatmaria Fatmaria
MSMuhammad Alif Sayyidinoor
Muhammad Alif Sayyidinoor
Candidiasis is a prevalent of fungal infection in tropical countries including Indonesia, with Candida albicans as the main causative agent (70–80%). C. albicans possesses key virulence factors including secreted aspartyl proteinase (SAP) and ERG11, which play crucial roles in pathogenesis and antifungal resistance. Durian peel (Durio zibethinus) is rich in bioactive compounds such as phenolics, flavonoids, and coumarins with potential antifungal properties, yet their mechanism of action remains poorly understood. This study aimed to investigate the potential of durian peel compounds as antagonists of SAP4-6 and ERG11 in C. albicans. This research employed an in silico bioinformatics approach. From 25 durian peel compounds analyzed, those meeting drug-likeness criteria were selected for molecular docking against target proteins SAP4-6 and ERG11, followed by pharmacokinetic and toxicity analyses. Eight compounds met drug-likeness criteria. Molecular docking results revealed several compounds with stronger binding affinities compared to the control (fluconazole), namely catechin (-7.1 kcal/mol) and epicatechin (-6.5 kcal/mol) for SAP4, cleomiscosin A (-9.1 kcal/mol) and cleomiscosin B (-9.2 kcal/mol) for SAP5, epicatechin and cleomiscosin A (-7.3 kcal/mol) for SAP6, and cleomiscosin A (-8.7 kcal/mol) and cleomiscosin B (-8.4 kcal/mol) for ERG11. Pharmacokinetic analysis showed these compounds possess good intestinal absorption and low toxicity profiles. Cleomiscosins A and B demonstrated the best potential as SAP4-6 and ERG11 antagonists in C. albicans with favorable pharmacokinetic and toxicity profiles.

29 October 2026 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
HHHusnul Havid
Husnul Havid
YYYsrafil Ysrafil
Ysrafil Ysrafil
FFFatmaria Fatmaria
Fatmaria Fatmaria
MMMuhammad Rifqi Musyaffa
Muhammad Rifqi Musyaffa
MSMasira Sony Crespo Sinuhaji
Masira Sony Crespo Sinuhaji
RPRemi Ayu Pratika
Remi Ayu Pratika
Background: Prostate cancer is major cause of cancer-related morbidity and mortality in men worldwide. Emerging evidence highlights the dragon scale fern ( Pyrrosia piloselloides or P. piloselloides ) has demonstrated anticancer potential, but its molecular mechanisms against prostate cancer remain unclear. The study aimed to investigate its potential anticancer compounds and underlying molecular mechanisms using an integrated in silico approach. Methods: A structured computational workflow integrating network pharmacology, molecular simulations, and MM/GBSA analysis was employed to explore the potential mechanism of bioactive compounds of P. piloselloides against prostate cancer-related targets. Additionally, the pharmacokinetic and toxicity profiles were evaluated using ADMET prediction. Results: Eight bioactive compounds of the plants were identified as potentially interacting with 32 prostate cancer-related proteins, including nine key targets: ESR1, MYC, CTNNB1, PPARG, AKT1, STAT3, BCL2, AR, and ERBB2. Clustering analysis identified 20 proteins within the major cluster, that subsequently dianalisis enrichment idapati bahwa mereka were associated with 235 molecular functions, 142 cellular components, and more than 1,000 biological processes, including epithelial cell proliferation dan identified terlibat dalam 161 enriched pathways, including the PI3K–Akt and ERBB signaling pathways. Docking analysis revealed variable predicted binding affinities, particularly for 7-dehydrodiosgenin 3-acetate against ERBB2 (− 11.85 kcal/mol), AKT1 (− 9.49 kcal/mol), and BCL2 (− 9.38 kcal/mol), stigmasterol against PPARG (− 9.63 kcal/mol), ERBB2 (− 9.94 kcal/mol), and AR (− 9.31 kcal/mol), and 6-hydroxymethaqualone against ESR1 (− 9.34 kcal/mol). Molecular dynamics simulations indicated overall structural stability with localized flexibility, while MM/GBSA analysis yielded favorable predicted binding free energies for ERBB2 with 6-hydroxymethaqualone (− 45.57 kcal/mol), PPARG with stigmasterol (− 41.52 kcal/mol), and BCL2 with 7-dehydrodiosgenin 3-acetate (− 23.35 kcal/mol). The compounds also showed generally favorable predicted ADMET profiles, providing basis for further experimental evaluation. Conclusion: The integrated computational analysis identified 6-hydroxymethaqualone, stigmasterol, and 7-dehydrodiosgenin 3-acetate as compounds with promising predicted interactions across prostate cancer-related targets. These findings provide a basis for further investigation and experimental validation.